GeneDx is set to acquire Fabric Genomics, an AI-powered genomic interpretation pioneer. The move is aimed at further decentralising DNA testing. Fabric Genomics operates a scalable platform used to interpret genetic disease cases, and the acquisition will allow health systems to perform sequencing in-house. The companies also anticipate faster diagnosis of genetic diseases, improved outcomes, and lower healthcare costs. GeneDx plans to expand its market reach in NICU genomic testing, newborn screening, and global commercial expansion.
Cloud Security Essentials – Protecting Multi-Cloud Environments
As multi-cloud environments gain traction for flexibility and cost efficiency, securing these infrastructures is critical. By 2025, 99% of cloud security failures will be due
